Astellas Pharma/ US04623U1025 /
2024-03-28 3:55:59 PM | Chg. -0.2097 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
10.7303USD | -1.92% | 21,135 Turnover: 220,784.4378 |
-Bid Size: - | -Ask Size: - | 25.77 bill.USD | - | - |
GlobeNewswire
03-19
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-07
LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire
2023-12-11
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the Unit...
GlobeNewswire
2023-10-19
Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold i...
GlobeNewswire
2023-09-14
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire
2023-09-11
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire
2022-03-11
ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Functi...
GlobeNewswire
2022-02-28
Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
GlobeNewswire
2022-02-22
Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol...
GlobeNewswire
2022-01-31
Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update
GlobeNewswire
2022-01-07
Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales mileston...
GlobeNewswire
2021-12-06
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors